<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03091179</url>
  </required_header>
  <id_info>
    <org_study_id>39202</org_study_id>
    <nct_id>NCT03091179</nct_id>
  </id_info>
  <brief_title>Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Short Laryngologic Surgery</brief_title>
  <official_title>The Safety and Efficacy of the Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Short Laryngologic Surgical Procedures.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether selected, short laryngologic surgical
      procedures can be safely and potentially more effectively performed without the use of
      endotracheal tube or jet ventilation, under completely tubeless conditions. The patient's gas
      exchange will be supported by rapid insufflation of high-flow oxygen through specialized
      nasal cannulae: the so called Transnasal Humidified Rapid- Insufflation Ventilatory Exchange
      (THRIVE).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 17, 2017</start_date>
  <completion_date type="Actual">July 18, 2018</completion_date>
  <primary_completion_date type="Actual">July 18, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average Oxygen Saturation by Pulse Oximetry (SpO2) (Primary Anesthesia Outcome)</measure>
    <time_frame>intraoperative (up to one hour)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to Awakening From Anesthesia (Primary Anesthesia Outcome)</measure>
    <time_frame>intraoperative (up to 20 min)</time_frame>
    <description>time from end of surgery to responding to commands/extubation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Suspension Time (Primary Surgical Outcome)</measure>
    <time_frame>intraoperative (up to 5 min)</time_frame>
    <description>Time required for the surgeon to position the patient's head and expose the surgical field for surgery using operating laryngoscope</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Suspension Repositioning Maneuvers (Primary Surgical Outcome)</measure>
    <time_frame>intraoperative (up to 5 min)</time_frame>
    <description>Number of attempts required for the surgeon to reposition the patient's head for optimal surgical exposure using operating laryngoscope</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of Surgery (Primary Surgical Outcome)</measure>
    <time_frame>intraoperative (up to one hour)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alertness</measure>
    <time_frame>Recovery room admission (up to 30 min following admission to recovery room)</time_frame>
    <description>Time required for the patient to become fully alert and oriented per standard recovery room evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery Room Time</measure>
    <time_frame>Up to 2 hours after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Pain Rating Scores</measure>
    <time_frame>Recovery room admission and discharge (up to 2 hours)</time_frame>
    <description>A score from 0 to 10, higher scores corresponding to higher pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>Recovery room admission and discharge (up to 2 hours)</time_frame>
    <description>Total oral opioid consumption in morphine milligram equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Voice Handicap Index (VHI)</measure>
    <time_frame>Preoperative assessment and one month after surgery</time_frame>
    <description>numerical scale, range from 0 to 40, with higher scores corresponding to worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Recovery</measure>
    <time_frame>One week after surgery</time_frame>
    <description>15-question survey, with each question scored from 0 to 10. Overall range 0-150, higher scores correspond to better outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Laryngologic Surgical Procedures</condition>
  <arm_group>
    <arm_group_label>THRIVE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high flow nasal oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endotracheal tube</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tracheal intubation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>THRIVE</intervention_name>
    <description>active nasal oxygen delivery system</description>
    <arm_group_label>THRIVE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endotracheal tube</intervention_name>
    <description>a plastic tube for mechanical ventilation</description>
    <arm_group_label>Endotracheal tube</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting for short, non-laser laryngologic surgery

        Exclusion Criteria:

          1. Patients with significantly decreased myocardial function (ejection fraction &lt; 50%)

          2. Patients with abnormal cardiac rhythm and conduction abnormalities, except for
             patients with isolated, asymptomatic premature atrial and ventricular contractions.

          3. Patients with significant peripheral vascular disease, such as those with the symptoms
             of intermittent claudication.

          4. Patients with known significant cerebrovascular disease, such as history of
             cerebrovascular accidents (CVAs) and transient ischemic attacks (TIAs).

          5. Patients with significant renal insufficiency, as manifested by estimated glomerular
             filtration rate (eGFR) &lt; 60 ml/min/1.73 m2.

          6. Patients with electrolyte (K+, Ca++) abnormalities, as determined by the lab values
             outside of a normal range.

          7. Patients with the history or symptoms of increased intracranial pressure or reduced
             intracranial compliance (e.g. headaches, nausea and vomiting, visual changes, mental
             changes).

          8. Patients with skull base defects.

          9. Patients with pulmonary hypertension who have pulmonary artery pressures above the
             normal range.

         10. Patients with significant chronic obstructive or restrictive lung diseases, as
             manifested by known history of baseline chronic hypoxia and/or hypercapnia, and/or
             baseline room air SpO2 &lt; 95%.

         11. Obese patients with BMI above 35 kg/m2.

        13. Patients with severe and poorly controlled gastroesophageal reflux disease despite
        medical treatment.

        14. Patients with hiatal hernia and full stomach patients. 15. Patient's refusal to
        participate in the study. 16. Patients who do not understand English or mentally
        handicapped. 17. Pregnant or breastfeeding patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vladimir Nekhendzy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford Hospital and Clinics</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Nekhendzy V, Saxena A, Mittal B, Sun E, Sung K, Dewan K, Damrose EJ. The Safety and Efficacy of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange for Laryngologic Surgery. Laryngoscope. 2020 Feb 20. doi: 10.1002/lary.28562. [Epub ahead of print]</citation>
    <PMID>32078170</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>March 5, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <results_first_submitted>June 21, 2019</results_first_submitted>
  <results_first_submitted_qc>June 21, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 17, 2019</results_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Vladimir Nekhendzy</investigator_full_name>
    <investigator_title>Clinical Professor of Anesthesiology and Otolaryngology</investigator_title>
  </responsible_party>
  <keyword>airway management</keyword>
  <keyword>high flow nasal oxygen</keyword>
  <keyword>high flow nasal cannula</keyword>
  <keyword>THRIVE</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 20, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/79/NCT03091179/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 15, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/79/NCT03091179/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>THRIVE</title>
          <description>THRIVE: active nasal oxygen delivery system</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>Endotracheal tube or Supraglottic jet ventilation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>THRIVE</title>
          <description>THRIVE: active nasal oxygen delivery system</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>Endotracheal tube or Supraglottic jet ventilation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.9" spread="12.42"/>
                    <measurement group_id="B2" value="55.2" spread="17.29"/>
                    <measurement group_id="B3" value="53.1" spread="14.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Average Oxygen Saturation by Pulse Oximetry (SpO2) (Primary Anesthesia Outcome)</title>
        <time_frame>intraoperative (up to one hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>THRIVE: active nasal oxygen delivery system</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Endotracheal tube or Supraglottic jet ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Average Oxygen Saturation by Pulse Oximetry (SpO2) (Primary Anesthesia Outcome)</title>
          <units>percentage of saturation (SpO2)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" spread="5.66"/>
                    <measurement group_id="O2" value="98.7" spread="1.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>P value was calculated using the means and standard deviations for each of the patient characteristics.</non_inferiority_desc>
            <p_value>0.006</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time to Awakening From Anesthesia (Primary Anesthesia Outcome)</title>
        <description>time from end of surgery to responding to commands/extubation</description>
        <time_frame>intraoperative (up to 20 min)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>THRIVE: active nasal oxygen delivery system</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Endotracheal tube or Supraglottic jet ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Awakening From Anesthesia (Primary Anesthesia Outcome)</title>
          <description>time from end of surgery to responding to commands/extubation</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.3" spread="4.0"/>
                    <measurement group_id="O2" value="9.4" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Suspension Time (Primary Surgical Outcome)</title>
        <description>Time required for the surgeon to position the patient's head and expose the surgical field for surgery using operating laryngoscope</description>
        <time_frame>intraoperative (up to 5 min)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>THRIVE: active nasal oxygen delivery system</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Endotracheal tube or Supraglottic jet ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Suspension Time (Primary Surgical Outcome)</title>
          <description>Time required for the surgeon to position the patient's head and expose the surgical field for surgery using operating laryngoscope</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="1.1"/>
                    <measurement group_id="O2" value="4.3" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Suspension Repositioning Maneuvers (Primary Surgical Outcome)</title>
        <description>Number of attempts required for the surgeon to reposition the patient's head for optimal surgical exposure using operating laryngoscope</description>
        <time_frame>intraoperative (up to 5 min)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>THRIVE: active nasal oxygen delivery system</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Endotracheal tube or Supraglottic jet ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Suspension Repositioning Maneuvers (Primary Surgical Outcome)</title>
          <description>Number of attempts required for the surgeon to reposition the patient's head for optimal surgical exposure using operating laryngoscope</description>
          <units>maneuvers</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.52"/>
                    <measurement group_id="O2" value="1.7" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Duration of Surgery (Primary Surgical Outcome)</title>
        <time_frame>intraoperative (up to one hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>THRIVE: active nasal oxygen delivery system</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Endotracheal tube or Supraglottic jet ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Surgery (Primary Surgical Outcome)</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.1" spread="10.82"/>
                    <measurement group_id="O2" value="20.9" spread="8.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Alertness</title>
        <description>Time required for the patient to become fully alert and oriented per standard recovery room evaluation</description>
        <time_frame>Recovery room admission (up to 30 min following admission to recovery room)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>THRIVE: active nasal oxygen delivery system</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Endotracheal tube or Supraglottic jet ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Alertness</title>
          <description>Time required for the patient to become fully alert and oriented per standard recovery room evaluation</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="6.3"/>
                    <measurement group_id="O2" value="4.8" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recovery Room Time</title>
        <time_frame>Up to 2 hours after procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>THRIVE: active nasal oxygen delivery system</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Endotracheal tube or Supraglottic jet ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Recovery Room Time</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.7" spread="43.41"/>
                    <measurement group_id="O2" value="77.7" spread="42.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Numerical Pain Rating Scores</title>
        <description>A score from 0 to 10, higher scores corresponding to higher pain</description>
        <time_frame>Recovery room admission and discharge (up to 2 hours)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>THRIVE: active nasal oxygen delivery system</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Endotracheal tube or Supraglottic jet ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Numerical Pain Rating Scores</title>
          <description>A score from 0 to 10, higher scores corresponding to higher pain</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>recovery room admission</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="1.95"/>
                    <measurement group_id="O2" value="3.7" spread="2.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>recovery room discharge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="1.29"/>
                    <measurement group_id="O2" value="2.7" spread="1.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Opioid Consumption</title>
        <description>Total oral opioid consumption in morphine milligram equivalents</description>
        <time_frame>Recovery room admission and discharge (up to 2 hours)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>THRIVE: active nasal oxygen delivery system</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Endotracheal tube or Supraglottic jet ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption</title>
          <description>Total oral opioid consumption in morphine milligram equivalents</description>
          <units>MME: morphine milligram equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" spread="11.0"/>
                    <measurement group_id="O2" value="22.5" spread="22.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Voice Handicap Index (VHI)</title>
        <description>numerical scale, range from 0 to 40, with higher scores corresponding to worse outcome</description>
        <time_frame>Preoperative assessment and one month after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>THRIVE: active nasal oxygen delivery system</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Endotracheal tube or Supraglottic jet ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Voice Handicap Index (VHI)</title>
          <description>numerical scale, range from 0 to 40, with higher scores corresponding to worse outcome</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.8" spread="12.63"/>
                    <measurement group_id="O2" value="22.7" spread="12.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>one month after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.6" spread="12.19"/>
                    <measurement group_id="O2" value="13.6" spread="13.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Recovery</title>
        <description>15-question survey, with each question scored from 0 to 10. Overall range 0-150, higher scores correspond to better outcome.</description>
        <time_frame>One week after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>THRIVE: active nasal oxygen delivery system</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Endotracheal tube or Supraglottic jet ventilation</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Recovery</title>
          <description>15-question survey, with each question scored from 0 to 10. Overall range 0-150, higher scores correspond to better outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="142.5" spread="15.7"/>
                    <measurement group_id="O2" value="131.2" spread="17.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>one month</time_frame>
      <group_list>
        <group group_id="E1">
          <title>THRIVE</title>
          <description>THRIVE: active nasal oxygen delivery system</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>Endotracheal tube or Supraglottic jet ventilation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Vladimir Nekhendzy</name_or_title>
      <organization>Stanford University</organization>
      <phone>650-498-4055</phone>
      <email>nek@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

